Results 11 to 20 of about 434,960 (396)

Heterologous expression of bacterial natural product biosynthetic pathways

open access: yesNatural Product Reports, 2019
Covering: 2013 to June 2018Heterologous expression of natural product biosynthetic pathways is of increasing interest in microbial biotechnology, drug discovery and optimization. It empowers not only the robust production of valuable biomolecules in more
Chengzhang Fu, Liujie Huo, Joachim J Hug
exaly   +2 more sources

Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis

open access: yesVaccines, 2022
A number of SARS-CoV-2 variants that have evolved to have significant immune escape have emerged worldwide since the COVID-19 outbreak. The efficacy of prime vaccination is waning with the evolution of SARS-CoV-2, and the necessity of booster doses is ...
Haoyue Cheng   +8 more
doaj   +1 more source

Homologous and Heterologous Covid-19 Booster Vaccinations

open access: yesNew England Journal of Medicine, 2022
BACKGROUND: Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are highly effective, breakthrough infections are occurring.
R. Atmar   +37 more
semanticscholar   +1 more source

Antibodies Induced by Homologous or Heterologous Inactivated (CoronaVac/BBIBP-CorV) and Recombinant Protein Subunit Vaccines (ZF2001) Dramatically Enhanced Inhibitory Abilities against B.1.351, B.1.617.2, and B.1.1.529 Variants

open access: yesVaccines, 2022
Safe and effective vaccines for Corona Virus Disease 2019 (COVID-19) can prevent the virus from infecting human populations and treat patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Xuesong Xu   +8 more
doaj   +1 more source

Immune Response of a Heterologous mRNA-1273 Second-Dose Immunization after a First Dose of ChadOx1 against SARS-CoV-2: A Cross-Sectional Study

open access: yesVaccines, 2022
Heterologous vaccination regimens could contribute to broadening vaccination coverage. To date, there is little evidence on the effectiveness of a combination of adenoviral COVID-19 vaccines with a second dose of mRNA vaccines.
Beatrice Albanesi   +12 more
doaj   +1 more source

Recombination between heterologous human acrocentric chromosomes

open access: yesbioRxiv, 2023
Comparisons within the human pangenome establish that homologous regions on short arms of heterologous human acrocentric chromosomes actively recombine, leading to the high rate of Robertsonian translocation breakpoints in these regions.
A. Guarracino   +11 more
semanticscholar   +1 more source

Factors involved in heterologous expression of proteins in E. coli host

open access: yesArchives of Microbiology, 2023
The production of recombinant proteins is one of the most significant achievements of biotechnology in the last century. These proteins are produced in the eukaryotic or prokaryotic heterologous hosts.
Mahin Pouresmaeil   +1 more
semanticscholar   +1 more source

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea [PDF]

open access: yesEpidemiology and Health, 2022
OBJECTIVES In Korea, a national coronavirus disease 2019 (COVID-19) vaccination program was implemented, including 4 vaccines against COVID-19. A text messaging-based survey, in addition to a passive adverse event reporting system, was launched to ...
Yunhyung Kwon   +7 more
doaj   +1 more source

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination

open access: yesNature Network Boston, 2021
Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination.
Joana Barros-Martins   +24 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy